| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494710A2 Diabetes-related immunoglobulin derived proteins, compostions, methods and uses |
| 01/12/2005 | EP1494701A2 Immunosuppressant compounds, methods and uses related thereto |
| 01/12/2005 | EP1494698A2 Compositions and methods for treating and preventing necrosis |
| 01/12/2005 | EP1494691A2 Treatment of diseases involving defective gap junctional communication |
| 01/12/2005 | EP1494683A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| 01/12/2005 | EP1494680A1 Use of carbon-2-modified-vitamin d analogs to induce the formation of new bone |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494665A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 01/12/2005 | EP1494658A1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| 01/12/2005 | EP1494546A2 Method for the production of potato juice products by means of food technology |
| 01/12/2005 | EP1494543A1 Dietary methods for canine performance enhancement |
| 01/12/2005 | EP1494542A1 Composition for modulating a physiological reaction or inducing an immune response |
| 01/12/2005 | EP1494536A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 01/12/2005 | EP1434773A4 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 01/12/2005 | EP1353918B1 Morpholine derivatives as antagonists of orexin receptors |
| 01/12/2005 | EP1313494B1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | EP1227734B1 Compositions comprising edible oils or fats and phytosterols and/or phytostanols dissolved therein |
| 01/12/2005 | EP1194044B1 Pharmaceutical or dietetic mushroom-based compositions and their use |
| 01/12/2005 | EP1083930A4 Insulin supplemented infant formula |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1564796A Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/12/2005 | CN1564687A Use of phosphodiesterase IV inhibitors |
| 01/12/2005 | CN1563087A Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 01/12/2005 | CN1563026A Glycoside class compound of phenethyl alcohol alcohol extracted from picria fel-terrae |
| 01/12/2005 | CN1563025A Segment of oligosaccharide alginic acd, preparation method and application |
| 01/12/2005 | CN1562970A PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 01/12/2005 | CN1562356A Biological degradable macromolecule microspheres of carrying insulin and preparation method |
| 01/12/2005 | CN1562340A Method for preparing technical product of lowering sugar of balsam pear containing active protein |
| 01/12/2005 | CN1562311A Decoction of Chinese traditional medicine for curing diabetes |
| 01/12/2005 | CN1562306A Health products for reducing blood sugar and blood fat in assistance |
| 01/12/2005 | CN1562303A Soft capsules of guifu dihuang and preparation method |
| 01/12/2005 | CN1562302A Nutritious drugs for improving children's intelligence |
| 01/12/2005 | CN1562288A Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases |
| 01/12/2005 | CN1562280A Application of cocoa extract in preparing medication of preventing and improving fatness and clinical symptom, and foodstuff |
| 01/12/2005 | CN1562279A Extract of cocoa tea in application for preparing medication and foodstuff of preventing and improving diabetes and clinical symptom |
| 01/12/2005 | CN1562277A Medication for treating ulcer of lower limb of patients of skin disease and diabetic, and preparation method |
| 01/12/2005 | CN1562251A Biological nutrient for male and method for preparing capsule |
| 01/12/2005 | CN1562217A Aqueous extract of irid and usage |
| 01/12/2005 | CN1562213A Nontoxic, non-anaphylactoid edible versatile nutriment as drug and cosmetic for beauty treatment and blacking hair and preparation method |
| 01/12/2005 | CN1562204A Technique of extracting acitve ingredient from roots, stems and leaves from artichoke and application |
| 01/12/2005 | CN1562192A Effervesce tablet of American ginseng containing vitamin C and preparation method |
| 01/12/2005 | CN1562188A Wasting-thirst preparaton and preparation method |
| 01/12/2005 | CN1562176A Preparation of Chinese traditional medicine for curing diabetes and preparation method |
| 01/12/2005 | CN1562111A Use of cassia sophera stem and leaf extract in preparing medicine for treating diabetes and improving its symptom |
| 01/12/2005 | CN1562096A Chinese-western medicine compound preparation and its preparing method |
| 01/12/2005 | CN1562095A Hawthorn essence defatting dripping pill and preparing method and its use |
| 01/12/2005 | CN1562094A Hawthorn essence defatting soft capsule preparing method and its use |
| 01/12/2005 | CN1562084A Method for preparing silkworm powder and its use |
| 01/12/2005 | CN1562081A Process for preparing livestock animal brain fat composite medicine |
| 01/12/2005 | CN1562073A Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/12/2005 | CN1562064A New use of saponin compound for treating cardiovascular disease |
| 01/12/2005 | CN1562050A Use of oligose alginate in anti-dementia and anti-diabetes |
| 01/12/2005 | CN1562048A Use of oligoxylose in preparing medicine for treating diabetes |
| 01/12/2005 | CN1562044A Witamin D2 calcium levulinate freeze-dried emulsion and its preparing method |
| 01/12/2005 | CN1562036A Nutrition supplement agent |
| 01/12/2005 | CN1562034A Glipizide metformin hydrochloride enteric preparation and method for measuring medicne release degree thereof |
| 01/12/2005 | CN1562014A V emulsion nicotinate for injection and its preparing method |
| 01/12/2005 | CN1561993A Silybum marianum dripping pill and its preparing method |
| 01/12/2005 | CN1561991A Process for producing medicine grade natural vitamin E raw oil |
| 01/12/2005 | CN1561980A Melbine hydrochloride enteric coatel slow-releasing preparation and its preparing method |
| 01/12/2005 | CN1561979A Micro capsule for choline chloride for ruminant stomach and its preparing method |
| 01/12/2005 | CN1561970A Fat soluble vitamin freeze-drying emulsion and its preparing method |
| 01/12/2005 | CN1561967A Nano grade vitamin micro emulsion and its preparing method |
| 01/12/2005 | CN1184317C Modifying method and application of exilis protein gene |
| 01/12/2005 | CN1184307C Industrial fermenting process of sphaeroid red bacteria and its fermented liquid |
| 01/12/2005 | CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 01/12/2005 | CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators |
| 01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
| 01/12/2005 | CN1184201C Method for producing one or more kinds of oxydic carotenoid dry powder |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183961C Remedies for bone metabolic errors |
| 01/12/2005 | CN1183956C Chinese medicinal capsule for treating gastroduodenal ulcer and II type diabetes |
| 01/12/2005 | CN1183943C Tea, medicated tea and buccal tablet for lowering blood pressure and reducing blood fat |
| 01/12/2005 | CN1183923C Medicine for treating diabetes and coronary heart disease |
| 01/12/2005 | CN1183911C Health-care medicine for improving vitality of old people and its prescription |
| 01/12/2005 | CN1183907C Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841554 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 01/11/2005 | US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 01/11/2005 | US6841549 Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| 01/11/2005 | US6841180 Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| 01/11/2005 | CA2369099C Anticonvulsant derivatives useful in reducing blood glucose levels |
| 01/11/2005 | CA2241244C Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/07/2005 | CA2470768A1 Crystal structure of osc |
| 01/06/2005 | WO2005000892A2 Glp-1 analog fusion plroteins |
| 01/06/2005 | WO2005000848A1 Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors |
| 01/06/2005 | WO2005000843A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | WO2005000829A1 Cannabinoid receptor modulator |
| 01/06/2005 | WO2005000820A2 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists |
| 01/06/2005 | WO2005000809A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |